Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis

Clinical trial NCT07472309 · COMPLETED

Trial details

NCT number: NCT07472309
Sponsor: Xijing Hospital of Digestive Diseases
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis (UC)Acute Severe Ulcerative Colitis Upadacitinib

Start date: 2023-06-06
Primary completion: 2026-03-03
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.